e the speed, scalability, and ï¬‚exibility of manufacturing, and to
nse across age groups, giving rise to an array of next generation
vaccine tetravalent (RIV4), using a baculovirus expression vector
, is the only one to have reached the market and has been
of rHA in RIV4 improve protective immune responses compared
a virus. In addition to the sequence integrity, characteristic of
HA in insect cells instills favourable tertiary and quaternary